Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association.
暂无分享,去创建一个
P. Ladenson | O. Clark | L. Braverman | G. Daniels | P. Singer | K. Ain | D. Cooper | P W Ladenson | P A Singer | E G Levy | G H Daniels | F. Greenspan | D S Cooper | F S Greenspan | L E Braverman | O H Clark | I R McDougall | K V Ain | S G Dorfman | E. Levy | I. McDougall | S. Dorfman
[1] I. Hay. Papillary Thyroid Carcinoma , 1990 .
[2] E. Kaplan,et al. Natural history, treatment, and course of papillary thyroid carcinoma. , 1990, The Journal of clinical endocrinology and metabolism.
[3] I. Narabayashi,et al. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. , 1993, Thyroid : official journal of the American Thyroid Association.
[4] B. Biondi,et al. Cardiac Effects of Long Term Thyrotropin-Suppressive Therapy with Levothyroxine* , 1993 .
[5] N. Ordóñez,et al. Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2. , 1996, Endocrinology and metabolism clinics of North America.
[6] E. Mazzaferri,et al. Management of a solitary thyroid nodule. , 1993, The New England journal of medicine.
[7] P. McCarthy,et al. Long-term follow-up of patients with benign thyroid fine-needle aspiration cytologic diagnoses. , 1989, Surgery.
[8] S. Jhiang,et al. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.
[9] T. Panzarella,et al. Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. , 1988, International journal of radiation oncology, biology, physics.
[10] E. Mazzaferri,et al. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. , 1981, The American journal of medicine.
[11] T. Miyamoto,et al. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. , 1994, The Journal of clinical endocrinology and metabolism.
[12] H. Gharib,et al. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases. , 1985, Mayo Clinic proceedings.
[13] J. Hershman,et al. Medical therapy for differentiated thyroid carcinoma. , 1994, Endocrine reviews.
[14] D. Cooper. Thyrosine suppression therapy for benign nodular disease , 1995 .
[15] E. Mazzaferri,et al. Pure follicular thyroid carcinoma: impact of therapy in 214 patients. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] J. Barentsz,et al. Large, Compressive Goiters Treated with Radioiodine , 1994, Annals of Internal Medicine.
[17] L. Wartofsky. Use of sensitive TSH assay to determine optimal thyroid hormone therapy and avoid osteoporosis. , 1991, Annual review of medicine.
[18] H. Gharib,et al. Fine-Needle Aspiration Biopsy of the Thyroid: An Appraisal , 1993, Annals of Internal Medicine.
[19] S. Refetoff,et al. Serum thyroglobulin in the management of patients with thyroid cancer. , 1982, Archives of internal medicine.
[20] D. Cooper. Clinical review 66: Thyroxine suppression therapy for benign nodular disease. , 1995, The Journal of clinical endocrinology and metabolism.
[21] D. Ross. Thyroid hormone suppressive therapy of sporadic nontoxic goiter. , 1992, Thyroid : official journal of the American Thyroid Association.